peroxynitrous acid has been researched along with zaprinast in 1 studies
| Studies (peroxynitrous acid) | Trials (peroxynitrous acid) | Recent Studies (post-2010) (peroxynitrous acid) | Studies (zaprinast) | Trials (zaprinast) | Recent Studies (post-2010) (zaprinast) |
|---|---|---|---|---|---|
| 3,303 | 21 | 1,230 | 576 | 2 | 87 |
| Protein | Taxonomy | peroxynitrous acid (IC50) | zaprinast (IC50) |
|---|---|---|---|
| cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 1.9442 | |
| cGMP-specific 3',5'-cyclic phosphodiesterase | Canis lupus familiaris (dog) | 0.76 | |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | Bos taurus (cattle) | 2.6 | |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | Homo sapiens (human) | 3.55 | |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | Bos taurus (cattle) | 2.6 | |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | Homo sapiens (human) | 3.55 | |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | Homo sapiens (human) | 3.55 | |
| cGMP-specific 3',5'-cyclic phosphodiesterase | Bos taurus (cattle) | 0.4 | |
| G-protein coupled receptor 35 | Homo sapiens (human) | 0.8294 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baber, SR; Bivalacqua, TJ; Champion, HC; Kadowitz, PJ; Nossaman, BD | 1 |
1 other study(ies) available for peroxynitrous acid and zaprinast
| Article | Year |
|---|---|
Analysis of vasodilator responses to peroxynitrite in the hindlimb vascular bed of the cat.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adamantane; Animals; Cats; Female; Hindlimb; Male; Meclofenamic Acid; Morpholines; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide Donors; Perfusion; Peroxynitrous Acid; Phosphodiesterase Inhibitors; Potassium Channel Blockers; Purinones; Regional Blood Flow; Rolipram; Sodium Nitrite; Splanchnic Circulation; Vascular Resistance; Vasoconstrictor Agents; Vasodilator Agents | 2007 |